Familial Risk Stratification Across Cancer Syndromes Using Fam3PRO

Genetics in Medicine · Published 2026-07-01 · DOI 10.1016/j.gim.2026.102665

Authors (13)

Jane W. Liang, Gregory E. Idos, Christine Hong, Kristen M. Shannon, Lauren M. Bear, Joseph D. Bonner, Sidney Lindsey, Jennifer Morales Pichardo, Zoe Guan, Anne Marie McCarthy, Stephen B. Gruber, Danielle Braun, Giovanni Parmigiani

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Liang, J., Idos, G., Hong, C., et al. (2026). Familial Risk Stratification Across Cancer Syndromes Using Fam3PRO. Genetics in Medicine. https://doi.org/10.1016/j.gim.2026.102665

Related articles

• Mitochondrial aminoacyl-tRNA synthetase (ARS)-defects: A review of phenotypes and therapeutic strategies in 899 patients · Genetics in Medicine · 2026 · Same journal
• Genomics to enhance newborn screening? · Genetics in Medicine · 2026 · Same journal
• The Evidence Aggregator: AI reasoning applied to rare disease diagnostics · Genetics in Medicine · 2026 · Same journal
• Germline ATRIP variants and the risk of ovarian cancer · Genetics in Medicine · 2026 · Same journal
• Indigenous perspectives on biobanking, specimen storage, and data governance: A scoping review · Genetics in Medicine · 2026 · Same journal
• RNU4ATAC-opathy: Clinical, molecular, and transcriptomic insights from a large cohort · Genetics in Medicine · 2026 · Same journal
• New genotype-phenotype correlations and management recommendations for individuals with RERE variants · Genetics in Medicine · 2026 · Same journal
• Beyond mistrust: Diverse biobanking preferences among parents and adolescents with sickle cell disease · Genetics in Medicine · 2026 · Same journal
• “It didn’t feel like anything unusual because we had already been through so much”: Disability-Related Research Experiences of Families with Children Enrolled in the Undiagnosed Diseases Network · Genetics in Medicine · 2026 · Same journal
• Clinical utility of exome sequencing: Post-exome testing decision changes in the management of children with suspected rare genetic disease · Genetics in Medicine · 2026 · Same journal